Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q1 2021 · 10-Q
Revenue$340.67M$340.67M+90.9% vs Q1 2020 Net Income$41.06M$41.06M+122.2% vs Q1 2020 EPS Diluted$3.46$3.46+121.8% vs Q1 2020 Gross Profit$248,547,000+83.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flow$65,326,000+144.3% Free Cash Flowderived$60,728,000+129.7% Margins · derivedGross margin73.0%−2.8 pt vs Q1 2020
Operating margin15.5%+2.3 pt vs Q1 2020
Net margin12.1%+1.7 pt vs Q1 2020
ended Mar 31, 2021 · filed May 4, 2021 · 34 d after period end